marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-06-2024
Protagonist Therapeutics Cash Flow 2011-2024 | PTGX
Annual Cash Flow Protagonist Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-70.2 M | -108 M | -108 M | -72.5 M | -41.5 M | -49.9 M | 3.87 M | -30 M | -14.4 M | - | - | - | - |
Depreciation & Amortization |
977 K | 1.03 M | 813 K | 948 K | 732 K | 527 K | 406 K | 317 K | 247 K | 258 K | - | - | - |
Accounts Payables |
772 K | 3.64 M | 1.6 M | 3.08 M | 2.79 M | 5.71 M | 1.26 M | 1.16 M | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Protagonist Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -27.4 M | - | - | - | -34.3 M | - | -76.5 M | - | -37.7 M | - | -80.9 M | - | -28.8 M | - | -53.6 M | -37.3 M | -15.8 M | - | -27.2 M | -13 M | -16.7 M | - | -39.8 M | -30.5 M | -15.1 M | - | 18 M | -22.7 M | -10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 236 K | - | - | - | 248 K | - | 778 K | - | 249 K | - | 578 K | - | 180 K | - | 601 K | 419 K | 217 K | - | 501 K | 306 K | 130 K | - | 399 K | 248 K | 78 K | - | 289 K | 181 K | 88 K | - | 242 K | 159 K | 73 K | - | 160 K | 111 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.63 M | 3.51 M | 772 K | 1.25 M | 4.57 M | 4.02 M | 3.64 M | 4.72 M | - | 7.16 M | 1.6 M | 706 K | 7.9 M | 2.73 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 2.79 M | 2.79 M | 2.79 M | 2.79 M | 5.71 M | 5.71 M | 5.71 M | 5.71 M | 1.26 M | 1.26 M | 1.26 M | 1.26 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 1.25 M | 1.25 M | 1.25 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency